Following the reverse stock split, Organovo’s common stock will continue to trade on the Nasdaq Capital Market under the symbol “ONVO” with a new CUSIP number of 68620A302.

This study highlights the link between plant-based diets and reduced IBD risk, suggesting dietary choices play a crucial role ...

Paola Papanicolaou, Head of Intesa Sanpaolo’s International Banks DivisionMILAN, March 17, 2025 (GLOBE NEWSWIRE) -- Speaking at the EIB Forum ...

Palantir stock climbed as analysts focused on potential new customers such as Walgreens at an artificial intelligence event called AIPCon.

Scientists have identified how a bacteria in the gut can act as a protective species against Salmonella infection. A team at ...

Nationally recognized pediatric gastroenterologist, Michael Dolinger, MD, MBA, joins Hassenfeld Children's Hospital at NYU Langone as director of the Pediatric Inflammatory Bowel Disease Program ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

Medscape Medical News, May 28, 2018 Old Drug May Get New Life in Parkinson's Prevention Inflammatory bowel disease raises the risk for Parkinson's disease, but anti-TNF therapy may reduce the risk ...

Millions of people around the world are today feeling the repercussions of President Donald Trump’s decision to freeze international aid for 90 days and shut down the U.S. Agency for ...

This move marks a significant progression in the treatment of inflammatory bowel disease (IBD). Under the terms of the acquisition, Organovo will receive an upfront payment and is eligible for ...